title: Fucosylated glycoproteomic approach to identify a complement component 9 associated with squamous cell lung cancer (SQLC).
abstract: Human lung cancer is a major cause of cancer mortality worldwide. Understanding the pathophysiological features and the development of novel biomarkers for diagnosis as well as treatment are major tasks. In the present study, sera from ten SQLC patients and healthy control (HEC) were collected and pooled, respectively. The pooled sera were depleted via an immunoaffinity method and further subjected to fucosylation enrichment. Enriched fucosylated glycoproteins were resolved by SDS-PAGE and subsequently analyzed by LC-ESI-MS/MS. From comparative proteomic analysis, we selected the C9 protein. C9 protein levels were validated by Western blot, protein arrays and the fucosylation levels of C9 by hybrid lectin ELISA (HLE) in the sera of 120 HEC and 118 SQLC patients. The C9 protein level was 6.4-fold higher in SQLC patients compared to HEC, as determined by Western blot analysis. The results were concurrently confirmed by a protein array that showed a C9 level significantly higher in SQLC patients, as compared to HEC, with a sensitivity of 53% and a specificity of 89%. C9 fucosylation levels were significantly higher in SQLC patients compared to HEC (p<0.05) when tested by HLE. These findings suggest that C9 and fucosylated form could serve as a useful marker for SQLC.
authors.affiliation: Department of Biochemistry, School of Dentistry, Kyungpook National University, & ProtAnBio Daegu, South Korea.
authors.forename: Arul
authors.initials: A
authors.lastname: Narayanasamy
authors.forename: Jung-Mo
authors.initials: JM
authors.lastname: Ahn
authors.forename: Hye-Jin
authors.initials: HJ
authors.lastname: Sung
authors.forename: Deok-Hoon
authors.initials: DH
authors.lastname: Kong
authors.forename: Kwon-Soo
authors.initials: KS
authors.lastname: Ha
authors.forename: Soo-Youn
authors.initials: SY
authors.lastname: Lee
authors.forename: Je-Yoel
authors.initials: JY
authors.lastname: Cho
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000097:blood*; D003186:Complement C9 / Q000378:metabolism*; D005643:Fucose / Q000097:blood; D006023:Glycoproteins / Q000097:blood*; D006031:Glycosylation; D006801:Humans; D008175:Lung Neoplasms / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000097:blood*; D018307:Neoplasms, Squamous Cell / Q000097:blood*
chemical_list: D014408:Biomarkers, Tumor; D003186:Complement C9; D006023:Glycoproteins; D009363:Neoplasm Proteins; D005643:Fucose